Los Altos, California, United States | Fund Name | Location |
| Canadian Medical Discoveries Fund | Canada, Halifax, Nova Scotia |
| CDH DIGITAL (HONG KONG) LIMITED | - |
| Clear Fir Partners | Seattle, United States, Washington |
| De Zhong Hui Keji Kaifa Zhongxin | China, Chongqing, Chongqing Shi |
| Deutsche Bank Alex. Brown | Baltimore, Maryland, United States |
| European Space Agency Business Incubation Centre, Noordwijk | France, Ile-de-France, Paris |
| FairPartner | Estonia, Harju maakond, Tallinn |
| FastVentures | Budapest, Hungary |
| Hangzhou Wangmei Investments | China, Hangzhou, Zhejiang |
| Hengxing Ventures | China, Hainan, Hainan Province |
| Huafengda Youxian Wangluo | Beijing, China, Shunyi |
| INO | Canada, Hamilton, Ontario |
| Kushiro Manufacturing | Hokkaido Prefecture, Japan, Kushiro |
| Samyakth Capital | - |
| Shang Qi Capital | China, Shanghai |
| Southern Progress Corporation | - |
| Tasheel Holding | Jeddah, Makkah, Saudi Arabia |
| Viventures Partners SA | France, Ile-de-France, Paris |
| Wise Venture | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Sopherion Therapeutics | $26M | 10 Mar 2003 | New Jersey, United States | ||
Raven Biotechnologies | $40M | 03 Jan 2003 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Sopherion Therapeutics | $26M | 10 Mar 2003 | New Jersey, United States | ||
Raven Biotechnologies | $40M | 03 Jan 2003 | South San Francisco, California, United States |
